Published in Vaccine Weekly, October 16th, 1995
MedImmune also holds an exclusive license to certain HPV vaccine technology developed by Georgetown University. HPV, which causes genital warts and cervical cancer, is the most common sexually transmitted disease in the United States. There are currently no vaccines to prevent this potentially serious infection.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.